Alexey Ruzin

4.0k total citations
44 papers, 2.7k citations indexed

About

Alexey Ruzin is a scholar working on Molecular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Alexey Ruzin has authored 44 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Medicine, 17 papers in Infectious Diseases and 15 papers in Molecular Biology. Recurrent topics in Alexey Ruzin's work include Antibiotic Resistance in Bacteria (22 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Bacterial biofilms and quorum sensing (7 papers). Alexey Ruzin is often cited by papers focused on Antibiotic Resistance in Bacteria (22 papers), Antimicrobial Resistance in Staphylococcus (15 papers) and Bacterial biofilms and quorum sensing (7 papers). Alexey Ruzin collaborates with scholars based in United States, Canada and Belgium. Alexey Ruzin's co-authors include Patricia A. Bradford, Richard P. Novick, David Keeney, Jodi A. Lindsay, Hope F. Ross, Fionnuala McAleese, Ellen Murphy, Peter J. Petersen, M Visalli and Steven J. Projan and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Alexey Ruzin

44 papers receiving 2.6k citations

Peers

Alexey Ruzin
Bruno Périchon France
Marc Galimand France
Linda M. Weigel United States
Rafael López-Rojas Spain
Göte Swedberg Sweden
Xiaogang Xu China
Xiaoting Hua China
N Claire Gordon United Kingdom
Michael J. McConnell Spain
Daria Van Tyne United States
Bruno Périchon France
Alexey Ruzin
Citations per year, relative to Alexey Ruzin Alexey Ruzin (= 1×) peers Bruno Périchon

Countries citing papers authored by Alexey Ruzin

Since Specialization
Citations

This map shows the geographic impact of Alexey Ruzin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexey Ruzin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexey Ruzin more than expected).

Fields of papers citing papers by Alexey Ruzin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexey Ruzin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexey Ruzin. The network helps show where Alexey Ruzin may publish in the future.

Co-authorship network of co-authors of Alexey Ruzin

This figure shows the co-authorship network connecting the top 25 collaborators of Alexey Ruzin. A scholar is included among the top collaborators of Alexey Ruzin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexey Ruzin. Alexey Ruzin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caballero, Julio Diaz, Rachel M. Wheatley, Natalia Kapel, et al.. (2023). Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients. Nature Communications. 14(1). 4083–4083. 37 indexed citations
2.
Coppens, Jasmine, Leen Timbermont, Agata Turlej-Rogacka, et al.. (2021). Evaluation of GeneXpert PA assay compared to genomic and (semi-)quantitative culture methods for direct detection of Pseudomonas aeruginosa in endotracheal aspirates. Antimicrobial Resistance and Infection Control. 10(1). 110–110. 3 indexed citations
3.
Tabor, David E., Fiona Fernandes, Annefleur C Langedijk, et al.. (2020). Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017−2018 INFORM-RSV Study. Journal of Clinical Microbiology. 59(1). 73 indexed citations
4.
Coppens, Jasmine, Liesbet Van Heirstraeten, Alexey Ruzin, et al.. (2019). Comparison of GeneXpert MRSA/SA ETA assay with semi-quantitative and quantitative cultures and nuc gene-based qPCR for detection of Staphylococcus aureus in endotracheal aspirate samples. Antimicrobial Resistance and Infection Control. 8(1). 4–4. 27 indexed citations
5.
Lü, Bin, Hui Liu, David E. Tabor, et al.. (2019). Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015–17. Scientific Reports. 9(1). 3898–3898. 58 indexed citations
6.
Ruzin, Alexey, Elizabeth Levin-Sparenberg, Xiaohui Jiang, et al.. (2018). Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States. PLoS ONE. 13(7). e0200319–e0200319. 16 indexed citations
7.
8.
Leeds, Jennifer A., et al.. (2013). In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin. Journal of Antimicrobial Chemotherapy. 69(1). 41–44. 62 indexed citations
9.
Ruzin, Alexey, Frederick W. Immermann, & Patricia A. Bradford. (2010). RT-PCR and Statistical Analyses of adeABC Expression in Clinical Isolates of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex. Microbial Drug Resistance. 16(2). 87–89. 37 indexed citations
10.
Petersen, Peter J., Alexey Ruzin, Margareta Tuckman, & C. Hal Jones. (2010). In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for diabetic foot infections. Diagnostic Microbiology and Infectious Disease. 66(4). 407–418. 11 indexed citations
11.
Ruzin, Alexey, Peter J. Petersen, & C. Hal Jones. (2009). Resistance development profiling of piperacillin in combination with the novel  -lactamase inhibitor BLI-489. Journal of Antimicrobial Chemotherapy. 65(2). 252–257. 15 indexed citations
12.
Ruzin, Alexey, Frederick W. Immermann, & Patricia A. Bradford. (2008). Real-Time PCR and Statistical Analyses of acrAB and ramA Expression in Clinical Isolates of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 52(9). 3430–3432. 40 indexed citations
13.
Keeney, David, Alexey Ruzin, & Patricia A. Bradford. (2007). RamA, a Transcriptional Regulator, and AcrAB, an RND-Type Efflux Pump, are Associated with Decreased Susceptibility to Tigecycline in Enterobacter cloacae. Microbial Drug Resistance. 13(1). 1–6. 87 indexed citations
14.
Ruzin, Alexey, David Keeney, & Patricia A. Bradford. (2007). AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complex. Journal of Antimicrobial Chemotherapy. 59(5). 1001–1004. 192 indexed citations
15.
Jennings, Lee D., Kenneth W. Foreman, Thomas S. Rush, et al.. (2004). Combinatorial synthesis of substituted 3-(2-indolyl)piperidines and 2-phenyl indoles as inhibitors of ZipA–FtsZ interaction. Bioorganic & Medicinal Chemistry. 12(19). 5115–5131. 43 indexed citations
16.
Jennings, Lee D., K.W. Foreman, Thomas S. Rush, et al.. (2004). Design and synthesis of indolo[2,3-a]quinolizin-7-one inhibitors of the ZipA–FtsZ interaction. Bioorganic & Medicinal Chemistry Letters. 14(6). 1427–1431. 45 indexed citations
17.
Ruzin, Alexey, Anatoly Severin, Soraya L. Moghazeh, et al.. (2003). Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus. Biochimica et Biophysica Acta (BBA) - General Subjects. 1621(2). 117–121. 54 indexed citations
18.
Novick, Richard P., Patrick M. Schlievert, & Alexey Ruzin. (2001). Pathogenicity and resistance islands of staphylococci. Microbes and Infection. 3(7). 585–594. 122 indexed citations
19.
Ruzin, Alexey, Jodi A. Lindsay, & Richard P. Novick. (2001). Molecular genetics of SaPI1 – a mobile pathogenicity island in Staphylococcus aureus. Molecular Microbiology. 41(2). 365–377. 152 indexed citations
20.
Lindsay, Jodi A., et al.. (1998). The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Molecular Microbiology. 29(2). 527–543. 297 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Périchon Breakdown of academic impact, for papers by Marc Galimand Breakdown of academic impact, for papers by Linda M. Weigel Breakdown of academic impact, for papers by Rafael López-Rojas Breakdown of academic impact, for papers by Göte Swedberg Breakdown of academic impact, for papers by Xiaogang Xu Breakdown of academic impact, for papers by Xiaoting Hua Breakdown of academic impact, for papers by N Claire Gordon Breakdown of academic impact, for papers by Michael J. McConnell Breakdown of academic impact, for papers by Daria Van Tyne
Rankless by CCL
2026